213 related articles for article (PubMed ID: 24694602)
21. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.
Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY
Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453
[TBL] [Abstract][Full Text] [Related]
22. Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery.
Teaima MH; El Mohamady AM; El-Nabarawi MA; Mohamed AI
Drug Dev Ind Pharm; 2020 May; 46(5):751-761. PubMed ID: 32250181
[TBL] [Abstract][Full Text] [Related]
23. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
24. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
25. In vitro characterisation of Span 65 niosomal formulations containing proteins.
Haj-Ahmad RR; Elkordy AA; Chaw CS
Curr Drug Deliv; 2015; 12(5):628-39. PubMed ID: 25963305
[TBL] [Abstract][Full Text] [Related]
26. Ophthalmic Bimatoprost-Loaded Niosomal In Situ Gel: Preparation, Optimization, and In Vivo Pharmacodynamics Study.
Aldawsari MF; Moglad EH; Alotaibi HF; Alkahtani HM; Khafagy ES
Polymers (Basel); 2023 Nov; 15(21):. PubMed ID: 37960016
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting.
Bragagni M; Mennini N; Ghelardini C; Mura P
J Pharm Pharm Sci; 2012; 15(1):184-96. PubMed ID: 22365096
[TBL] [Abstract][Full Text] [Related]
28. Enhanced oral bioavailability of griseofulvin via niosomes.
Jadon PS; Gajbhiye V; Jadon RS; Gajbhiye KR; Ganesh N
AAPS PharmSciTech; 2009; 10(4):1186-92. PubMed ID: 19856107
[TBL] [Abstract][Full Text] [Related]
29. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study.
Emad Eldeeb A; Salah S; Ghorab M
Drug Deliv; 2019 Dec; 26(1):509-521. PubMed ID: 31090464
[TBL] [Abstract][Full Text] [Related]
30. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
Rasul A; Imran Khan M; Ur Rehman M; Abbas G; Aslam N; Ahmad S; Abbas K; Akhtar Shah P; Iqbal M; Ahmed Al Subari AM; Shaheer T; Shah S
Int J Nanomedicine; 2020; 15():7937-7949. PubMed ID: 33116510
[TBL] [Abstract][Full Text] [Related]
31. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
Fouda NH; Abdelrehim RT; Hegazy DA; Habib BA
Drug Deliv; 2018 Nov; 25(1):1340-1349. PubMed ID: 29869516
[TBL] [Abstract][Full Text] [Related]
32. Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s).
Negi P; Aggarwal M; Sharma G; Rathore C; Sharma G; Singh B; Katare OP
Biomed Pharmacother; 2017 Apr; 88():480-487. PubMed ID: 28126673
[TBL] [Abstract][Full Text] [Related]
33. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor.
El-Sayed MM; Hussein AK; Sarhan HA; Mansour HF
Drug Dev Ind Pharm; 2017 Jun; 43(6):902-910. PubMed ID: 27977311
[TBL] [Abstract][Full Text] [Related]
34. Growth Factor-Loaded Nano-niosomal Gel Formulation and Characterization.
Moghassemi S; Hadjizadeh A; Hakamivala A; Omidfar K
AAPS PharmSciTech; 2017 Jan; 18(1):34-41. PubMed ID: 27502406
[TBL] [Abstract][Full Text] [Related]
35. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
[TBL] [Abstract][Full Text] [Related]
36. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
Abdelkader H; Ismail S; Kamal A; Alany RG
Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
[TBL] [Abstract][Full Text] [Related]
37. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.
Allam A; Fetih G
Drug Des Devel Ther; 2016; 10():2421-33. PubMed ID: 27536063
[TBL] [Abstract][Full Text] [Related]
38. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system.
Hasan AA; Madkor H; Wageh S
Drug Deliv; 2013; 20(3-4):120-6. PubMed ID: 23651102
[TBL] [Abstract][Full Text] [Related]
39. Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting.
Ravouru N; Kondreddy P; Korakanchi D; Haritha M
Curr Drug Discov Technol; 2013 Dec; 10(4):270-82. PubMed ID: 23863098
[TBL] [Abstract][Full Text] [Related]
40. Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma.
Allam A; Elsabahy M; El Badry M; Eleraky NE
Int J Pharm; 2021 Apr; 598():120380. PubMed ID: 33609725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
